Phase 2 trial results show XProâ„¢ benefits cognition in certain early Alzheimer's patients, pending further data analysis and FDA designation. INmune Bio Inc. announced results from its Phase 2 MINDFuL ...
Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients with resectable non–small-cell lung cancer (NSCLC). Perioperative regimens may combine benefits of both to improve long-term ...
For adults at risk for HIV acquisition or people with HIV (PWH) not taking daily antiretroviral therapy (ART), an HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback